AMED Amedisys Inc
Price (delayed)
$92.09
Market cap
$3.53B
P/E Ratio
69.77
Dividend/share
N/A
EPS
$1.32
Enterprise value
$3.69B
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients,
Highlights
The P/E is 50% below the 5-year quarterly average of 140.6
The quick ratio has increased by 23% YoY and by 4.5% QoQ
AMED's EPS is down by 48% from the previous quarter
The net income has decreased by 48% QoQ
Key stats
What are the main financial stats of AMED
Market
Valuations
Earnings
Shares outstanding
38.37M
Market cap
$3.53B
Enterprise value
$3.69B
Price to earnings (P/E)
69.77
Price to book (P/B)
2.66
Price to sales (P/S)
1.28
EV/EBIT
30.23
EV/EBITDA
20.21
EV/Sales
1.57
Revenue
$2.35B
Gross profit
$1.02B
Operating income
$94.54M
Net income
$43.23M
EBIT
$122.05M
EBITDA
$182.51M
Free cash flow
$215.12M
Per share
Balance sheet
Liquidity
EPS
$1.32
EPS diluted
$1.31
Free cash flow per share
$6.57
Book value per share
$34.64
Revenue per share
$71.77
TBVPS
$25.79
Total assets
$2.14B
Total liabilities
$958.75M
Debt
$459.3M
Equity
$1.13B
Working capital
$117.69M
Debt to equity
0.4
Current ratio
1.23
Quick ratio
1.17
Net debt/EBITDA
0.86
Margins
Efficiency
Dividend
EBITDA margin
7.8%
Gross margin
43.3%
Net margin
1.8%
Operating margin
4%
Return on assets
2%
Return on equity
3.8%
Return on invested capital
21.7%
Return on capital employed
7.5%
Return on sales
5.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMED stock price
How has the Amedisys stock price performed over time
Intraday
0.07%
1 week
-0.01%
1 month
-0.46%
1 year
-1.31%
YTD
1.43%
QTD
1.43%
Financial performance
How have Amedisys's revenue and profit performed over time
Revenue
$2.35B
Gross profit
$1.02B
Operating income
$94.54M
Net income
$43.23M
Gross margin
43.3%
Net margin
1.8%
The company's net margin has shrunk by 50% QoQ
The net income has decreased by 48% QoQ
The company's operating margin fell by 43% YoY and by 38% QoQ
AMED's operating income is down by 40% year-on-year and by 36% since the previous quarter
Growth
What is Amedisys's growth rate over time
Valuation
What is Amedisys stock price valuation
P/E
69.77
P/B
2.66
P/S
1.28
EV/EBIT
30.23
EV/EBITDA
20.21
EV/Sales
1.57
The P/E is 50% below the 5-year quarterly average of 140.6
AMED's EPS is down by 48% from the previous quarter
The P/B is 51% less than the 5-year quarterly average of 5.4
AMED's equity is up by 6% year-on-year
The P/S is 42% less than the 5-year quarterly average of 2.2
Amedisys's revenue has increased by 5% YoY
Efficiency
How efficient is Amedisys business performance
The ROIC has soared by 81% YoY but it has contracted by 24% from the previous quarter
AMED's ROS has soared by 63% YoY but it is down by 28% from the previous quarter
The ROE has contracted by 49% from the previous quarter
The ROA has declined by 49% since the previous quarter
Dividends
What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMED.
Financial health
How did Amedisys financials performed over time
AMED's total assets is 123% higher than its total liabilities
The quick ratio has increased by 23% YoY and by 4.5% QoQ
The current ratio has increased by 17% YoY and by 3.4% QoQ
The company's debt is 60% lower than its equity
The debt to equity has contracted by 13% YoY and by 2.4% from the previous quarter
AMED's equity is up by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.